Compare Godaddy Inc (GDDY) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Godaddy Inc trades at $102.04 (market cap $13.07B), while Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B). The key difference: Godaddy Inc is far larger — about 7.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Godaddy Inc is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| GDDY | NUVB | |
|---|---|---|
Market Cap | $13.07B | $1.74B |
Volume | 1,831,274 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $135.18 | $9.54 |
52-Week Low | $75.07 | $3.41 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $15.75B | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $97.21, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company maintains strong fundamentals with consistent earnings beats, posting $4.95B revenue and $875M net income in 2025. Valuation metrics appear reasonable with P/E of 14.44 and P/S of 2.58. However, the stock faces significant headwinds from multiple securities class action lawsuits alleging misrepresentation of domain contract terms, creating investor uncertainty despite positive financial performance.
The outlook remains mixed with strong operational performance offset by legal risks. Analyst consensus leans bullish with 57.9% buy ratings and $96.20 price target, but the numerous securities lawsuits represent material downside risk. Investors should weigh the company's solid profitability and cash flow generation against potential legal liabilities and reputational damage from the ongoing litigation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
